Cambridge Biomedical is positioned to provide support throughout the drug development process, from preclinical through phase IV clinical trials and post-market commercial testing.
Leading with science, we deliver innovative solutions with quality and exceptional service to meet and exceed your needs for clinical research and testing. Cambridge Biomedical offer established expertise in assay development, assay validation, and specimen analysis for biomarkers and bioanalytical assays (PK, PD, immunogenicity).
We provide a diverse range of simple to highly complex, routine and esoteric assays using a wide range of technologies; and we accommodate study sizes with low, medium, or high volume sample testing requirements.
Our laboratory is CLIA certified, CAP accredited, and GLP/GCLP compliant.
Cambridge Biomedical supports local and global drug development efforts with its core competencies in following technologies:
- Flow Cytometry
- Cell Based Assays